Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Kinevant Sciences Logo
Kinevant Sciences CB Rank
408755
Heat Score
51
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.
Founded
obfuscation
Private New York, New York, United States1-10 kinevant.com/
Biopharma
Biotechnology
Health Care
Pharmaceutical
Overview

Kinevant Sciences
Heat Score
51

Growth Score
pts
in past quarter
Heat Score 51
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Kinevant Sciences

CB Rank
408755
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.
Founded
obfuscation
Private New York, New York, United States1-10 kinevant.com/
Biopharma
Biotechnology
Health Care
Pharmaceutical

Key People

  • Photo of Bill Gerhart
    Bill Gerhart: Chief Executive Officer
    Past Role: Patara Pharma, Founder & CEO

Details

Legal Name Kinevant Sciences, Inc.
Operating Status Active
Company Type For Profit
About the Company
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.
Contact Email info@kinevant.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Namilumab
Namilumab is a fully human monoclonal antibody that inhibits GM-CSF, designed for once-monthly subcutaneous injection to treat pulmonary sarcoidosis by reducing inflammation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 14

Employee Profiles

News

News and Press

News•Mar 27, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 27, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$264.1KThis year, Kinevant Sciences is projected to spend $264.1K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
The New York Times Logo
The New York Times
82
Shopper Recognition Logo
Shopper Recognition
76
Video Game Patent Logo
Video Game Patent
75

Active Website Tech Count

3Kinevant Sciences is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Greenhouse.
Sub-Organizations
Frequently Asked Questions

Where is Kinevant Sciences's headquarters? Kinevant Sciences is located in New York, New York, United States.Who are Kinevant Sciences's competitors? Alternatives and possible competitors to Kinevant Sciences may include AbbVie, Sanofi, and  Cytokinetics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|